ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
Open accessAbstract
CONTEXT: More than 1.5 million US adults use stimulants and other medications labeled for treatment of attention-deficit/hyperactivity disorder (ADHD). These agents can increase heart rate and blood pressure, raising concerns about their cardiovascular safety. OBJECTIVE: To examine whether current use of medications prescribed primarily to treat ADHD is associated with increased risk of serious cardiovascular events in young and middle-aged adults. DESIGN, SETTING, AND PARTICIPANTS: Retrospective, population-based cohort study using electronic health care records from 4 study sites (OptumInsight Epidemiology, Tennessee Medicaid, Kaiser Permanente California, and the HMO Research Network), starting in 1986 at 1 site and ending in 2005 at all sites, with additional covariate assessment using 2007 survey data. Participants were adults aged 25 through 64 years with dispensed prescriptions for methylphenidate, amphetamine, or atomoxetine at baseline. Each medication user (n = 150,359) was matched to 2 nonusers on study site, birth year, sex, and calendar year (443,198 total users and nonusers). MAIN OUTCOME MEASURES: Serious cardiovascular events, including myocardial infarction (MI), sudden cardiac death (SCD), or stroke, with comparison between current or new users and remote users to account for potential healthy-user bias. RESULTS: During 806,182 person-years of follow-up (median, 1.3 years per person), 1357 cases of MI, 296 cases of SCD, and 575 cases of stroke occurred. There were 107,322 person-years of current use (median, 0.33 years), with a crude incidence per 1000 person-years of 1.34 (95% CI, 1.14-1.57) for MI, 0.30 (95% CI, 0.20-0.42) for SCD, and 0.56 (95% CI, 0.43-0.72) for stroke. The multivariable-adjusted rate ratio (RR) of serious cardiovascular events for current use vs nonuse of ADHD medications was 0.83 (95% CI, 0.72-0.96). Among new users of ADHD medications, the adjusted RR was 0.77 (95% CI, 0.63-0.94). The adjusted RR for current use vs remote use was 1.03 (95% CI, 0.86-1.24); for new use vs remote use, the adjusted RR was 1.02 (95% CI, 0.82-1.28); the upper limit of 1.28 corresponds to an additional 0.19 events per 1000 person-years at ages 25-44 years and 0.77 events per 1000 person-years at ages 45-64 years. CONCLUSIONS: Among young and middle-aged adults, current or new use of ADHD medications, compared with nonuse or remote use, was not associated with an increased risk of serious cardiovascular events. Apparent protective associations likely represent healthy-user bias.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Two large studies reported no significant increase in risk for cardiovascular events in current users of ADHD medications compared with nonusers.
“However, these findings should be considered in light of data from 2 large studies that reported no significant increase in risk for cardiovascular events in current users of ADHD medications compared with nonusers (262, 263).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Antman, E. M., Bassand, J., Klein, W. W., Ohman, M. E., Sendón, J. L. L., Rydén, L., Simoons, M. L., & Tendera, M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00804-4 · Cited by 4,824 · see citing works
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646 · see citing works
Self-citationThygesen, S. K., Christiansen, C. F., Christensen, S., Lash, T. L., & Sørensen, H. T. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-83 · Cited by 1,196 · see citing works
Schneeweiß, S. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1200 · Cited by 731 · see citing works
Methylphenidate: Its Pharmacology and Uses
Challman, T. D., & Lipsky, J. J. (2000) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64618-1 · Cited by 560 · see citing works
Indications for propensity scores and review of their use in pharmacoepidemiology
Glynn, R. J., Schneeweiss, S., & Stürmer, T. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_293.x · Cited by 541 · see citing works
Guidelines for the Pharmacologic Treatment of Neurobehavioral Sequelae of Traumatic Brain Injury
Warden, D. L., Gordon, B., McAllister, T. W., Silver, J., Barth, J. T., Bruns, J. J., Drake, A., Gentry, T., Jagoda, A. S., Katz, D. I., et al. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.1468 · Cited by 438 · see citing works
ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults
Cooper, W. O., Habel, L. A., Sox, C. M., Chan, K. A., Arbogast, P. G., Cheetham, T. C., Murray, K. T., Quinn, V. P., Stein, C. M., Callahan, S. T., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1110212 · Cited by 411 · see citing works
Self-citationSTRATIFICATION BY A MULTIVARIATE CONFOUNDER SCORE
Miettinen, O. S. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112339 · Cited by 351 · see citing works
Stiefel, G., & Besag, F. (2010) · Drug Safety · doi:10.2165/11536380-000000000-00000 · Cited by 256 · see citing works
Sudden Death and Use of Stimulant Medications in Youths
Gould, M. S., Walsh, B. T., Munfakh, J. L., Kleinman, M., Duan, N., Olfson, M., Greenhill, L., & Cooper, T. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040472 · Cited by 253 · see citing works
Cardiovascular Events and Death in Children Exposed and Unexposed to ADHD Agents
Schelleman, H., Bilker, W. B., Strom, B. L., Kimmel, S. E., Newcomb, C., Guevara, J. P., Daniel, G. W., Cziraky, M. J., & Hennessy, S. (2011) · Pediatrics · doi:10.1542/peds.2010-3371 · Cited by 159 · see citing works
Use of disease risk scores in pharmacoepidemiologic studies
Arbogast, P. G., & Ray, W. A. (2008) · Statistical Methods in Medical Research · doi:10.1177/0962280208092347 · Cited by 135 · see citing works
Self-citationPeterson, K., McDonagh, M. S., & Fu, R. (2008) · Psychopharmacology · doi:10.1007/s00213-007-0996-4 · Cited by 135 · see citing works
Validity of Pharmacoepidemiologic Drug and Diagnosis Data
West, S. L., Strom, B. L., & Poole, C. (2006) · Pharmacoepidemiology · doi:10.1002/9780470059876.ch45 · Cited by 134 · see citing works
McCarthy, S., Cranswick, N., Potts, L., Taylor, E., & Wong, I. C. K. (2009) · Drug Safety · doi:10.2165/11317630-000000000-00000 · Cited by 128 · see citing works
Winterstein, A. G., Gerhard, T., Shuster, J., Johnson, M., Zito, J. M., & Saidi, A. (2007) · Pediatrics · doi:10.1542/peds.2007-0675 · Cited by 119 · see citing works
Awudu, G. A. H., & Besag, F. (2014) · Drug Safety · doi:10.1007/s40264-014-0201-8 · Cited by 116 · see citing works
An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults
Wilens, T. E., Morrison, N. R., & Prince, J. B. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.137 · Cited by 113 · see citing works
Adjusting for Unmeasured Confounders in Pharmacoepidemiologic Claims Data Using External Information
Schneeweiß, S., Glynn, R. J., Tsai, E. H., Avorn, J., & Solomon, D. H. (2004) · Epidemiology · doi:10.1097/01.ede.0000147164.11879.b5 · Cited by 112 · see citing works
Adler, L. A., Zimmerman, B., Starr, H. L., Silber, S., Palumbo, J., Orman, C., & Spencer, T. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a390ce · Cited by 106 · see citing works
The New Definition of Myocardial Infarction
Meier, M. A., Al-Badr, W. H., Cooper, J. V., Kline-Rogers, E. M., Smith, D. E., Eagle, K. A., & Mehta, R. H. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.14.1585 · Cited by 105 · see citing works
Self-citationInfluence of Methylphenidate on Eating in Obese Men
Leddy, J. J., Epstein, L. H., Jaroni, J. L., Roemmich, J. N., Paluch, R. A., Goldfield, G. S., & Lerman, C. E. (2004) · Obesity Research · doi:10.1038/oby.2004.29 · Cited by 104 · see citing works
de Burgos-Lunar, C., Salinero-Fort, M. A., Cárdenas-Valladolid, J., Soto-Díaz, S., Fuentes-Rodríguez, C. Y., Abánades-Herranz, J. C., & del Cura-González, I. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-146 · Cited by 96 · see citing works
Grijalva, C. G., Chung, C. P., Stein, C. M., Gideon, P. S., Dyer, S. M., Mitchel, E. F., & Griffin, M. R. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1625 · Cited by 58 · see citing works
Cardiac Safety of Methylphenidate Versus Amphetamine Salts in the Treatment of ADHD
Winterstein, A. G., Gerhard, T., Shuster, J., & Saidi, A. (2009) · Pediatrics · doi:10.1542/peds.2008-3138 · Cited by 56 · see citing works
A computer case definition for sudden cardiac death
Chung, C. P., Murray, K. T., Stein, C. M., Hall, K., & Ray, W. A. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1888 · Cited by 51 · see citing works
Self-citationAdult ADHD: prevalence of diagnosis in a US population with employer health insurance
Montejano, L. B., Sasané, R., Hodgkins, P., Russo, L., & Huse, D. M. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.603302 · Cited by 48 · see citing works
Atomoxetine and Cerebrovascular Outcomes in Adults
Holick, C. N., Turnbull, B., Jones, M., Chaudhry, S., Bangs, M. E., & Seeger, J. D. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181b2b828 · Cited by 42 · see citing works
Alpert, J., Antman, E., Apple, F., Armstrong, P. W., Bassand, J., de Luna, A. D., Beller, G., Breithardt, G., Chaitman, B., Clemmensen, P., et al. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2305 · Cited by 37 · see citing works
Stimulant Medications and Attention Deficit–Hyperactivity Disorder
Cohen, A. L., Jhung, M. A., & Budnitz, D. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmc060860 · Cited by 34 · see citing works
Validity of Pharmacoepidemiologic Drug and Diagnosis Data
West, S. L., Ritchey, M. E., & Poole, C. (2012) · Pharmacoepidemiology · doi:10.1002/9781119959946.ch41 · Cited by 31 · see citing works
Recent advances in poststroke depression
Tharwani, H. M., Yerramsetty, P., Mannelli, P., Patkar, A. A., & Masand, P. S. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0023-9 · Cited by 29 · see citing works
Psychostimulants for depression in the medically ill.
Rl, F., Jj, W., & Tabler, J. B. (1991) · PubMed · Cited by 27 · see citing works
Adult Attention-Deficit/Hyperactivity Disorder Treatment and Cardiovascular Implications
Hammerness, P. G., Surman, C. B. H., & Chilton, A. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0213-3 · Cited by 24 · see citing works
Adjusted Odds Ratios for Case-Control Studies with Missing Confounder Data in Controls
Suissa, S., & Edwardes, M. D. D. (1997) · Epidemiology · doi:10.1097/00001648-199705000-00008 · Cited by 17 · see citing works
ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults
Mack, A. H. (2012) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/j.ypsy.2012.08.072 · Cited by 6 · see citing works
McCarthy, S., Cranswick, N., Potts, L., Taylor, E., & Wong, I. C. K. (2009) · UCL Discovery (University College London) · Cited by 5 · see citing works
Cardiovascular Events and Death in Children Exposed and Unexposed to ADHD Agents
(2011) · PEDIATRICS · doi:10.1542/peds.2010-3371d · Cited by 5 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [36]Cohen AL Jhung MA Budnitz DS Stimulant medications and attention deficithyperactivity disorder N Engl J Med 2006 354 21 2294 2295 16723627
Cited by
Sorted by citations
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237 · see citing works
Attention-deficit hyperactivity disorder
Posner, J., Polanczyk, G. V., & Sonuga-Barke, E. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33004-1 · Cited by 835 · see citing works
Updated European Consensus Statement on diagnosis and treatment of adult ADHD
Kooij, J. J. S., Bijlenga, D., Salerno, L., Jaeschke, R., Bitter, I., Balázs, J., Thome, J., Dom, G., Kasper, S., Nunes Filipe, C., et al. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2018.11.001 · Cited by 686 · see citing works
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631 · see citing works
Drugs That May Cause or Exacerbate Heart Failure
Page, R. L., II, O’Bryant, C. L., Cheng, D., Dow, T. J., Ky, B., Stein, C. M., Spencer, A. P., Trupp, R. J., & Lindenfeld, J. M. (2016) · Circulation · doi:10.1161/cir.0000000000000426 · Cited by 474 · see citing works
The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration
Ross, T. R., Ng, D., Brown, J. S., Pardee, R., Hornbrook, M., Hart, G., & Steiner, J. (2014) · eGEMs · doi:10.13063/2327-9214.1049 · Cited by 400 · see citing works
Cohen, M. I., Triedman, J. K., Cannon, B. C., Davis, A. M., Drago, F., Janoušek, J., Klein, G. J., Law, I. H., Morady, F., Paul, T., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.03.050 · Cited by 379 · see citing works
Cortese, S., Holtmann, M., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Graham, J., Taylor, E., Sergeant, J., et al. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12036 · Cited by 336 · see citing works
Storebø, O. J., Pedersen, N., Ramstad, E., Kielsholm, M. L., Nielsen, S. S., Krogh, H. B., Moreira-Maia, C. R., Magnusson, F. L., Holmskov, M., Gerner, T., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012069.pub2 · Cited by 321 · see citing works
Lakhan, S. E., & Kirchgessner, A. L. (2012) · Brain and Behavior · doi:10.1002/brb3.78 · Cited by 241 · see citing works
Adult Attention Deficit–Hyperactivity Disorder
Volkow, N. D., & Swanson, J. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1212625 · Cited by 227 · see citing works
Hennissen, L., Bakker, M. J., Banaschewski, T., Carucci, S., Coghill, D., Danckaerts, M., Dittmann, R., Hollis, C. P., Kovshoff, H., McCarthy, S., et al. (2017) · CNS Drugs · doi:10.1007/s40263-017-0410-7 · Cited by 225 · see citing works
Fredriksen, M., Halmøy, A., Faraone, S. V., & Haavik, J. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.016 · Cited by 173 · see citing works
Chang, Z., Ghirardi, L., Quinn, P. D., Asherson, P., D’Onofrio, B. M., & Larsson, H. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.009 · Cited by 175 · see citing works
Kovacs, A. H., Brouillette, J., Ibeziako, P. I., Jackson, J. L., Kasparian, N. A., Kim, Y. Y., Livecchi, T., Sillman, C., & Kochilas, L. K. (2022) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000110 · Cited by 180 · see citing works
Tardelli, V. S., Bisaga, A., Arcadepani, F. B., Gerra, G., Levin, F. R., & Fidalgo, T. M. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05563-3 · Cited by 151 · see citing works
Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases
Zhang, L., Li, L., Andell, P., Garcia‐Argibay, M., Quinn, P. D., D'Onofrio, B. M., Brikell, I., Kuja‐Halkola, R., Lichtenstein, P., Johnell, K., et al. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.4294 · Cited by 158 · see citing works
Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review
Westover, A. N., & Halm, E. A. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-41 · Cited by 141 · see citing works
Ojangba, T., Boamah, S., Miao, Y., Guo, X., Fen, Y., Agboyibor, C., Yuan, J., & Dong, W. (2023) · The Journal of Clinical Hypertension · doi:10.1111/jch.14653 · Cited by 136 · see citing works
Mick, E. O., McManus, D. D., & Goldberg, R. J. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.06.011 · Cited by 134 · see citing works
Overview of attention deficit hyperactivity disorder in young children
Singh, A., Yeh, C. J., Verma, N., & Das, A. K. (2015) · Health Psychology Research · doi:10.4081/hpr.2015.2115 · Cited by 133 · see citing works
Martínez-Raga, J., Knecht, C., Szerman, N., & Martinez, M. I. (2012) · CNS Drugs · doi:10.1007/s40263-012-0019-9 · Cited by 128 · see citing works
Dalsgaard, S., Kvist, A. P., Leckman, J. F., Nielsen, H. S., & Simonsen, M. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0020 · Cited by 121 · see citing works
Awudu, G. A. H., & Besag, F. (2014) · Drug Safety · doi:10.1007/s40264-014-0201-8 · Cited by 116 · see citing works
An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder
da Silva, B. S., Grevet, E. H., Silva, L. C. F., Ramos, J. K. N., Rovaris, D. L., & Bau, C. H. D. (2023) · Discover Mental Health · doi:10.1007/s44192-022-00030-1 · Cited by 125 · see citing works
Metcalfe, A., Neudam, A., Forde, S., Liu, M., Drösler, S. E., Quan, H., & Jetté, N. (2012) · Health Services Research · doi:10.1111/j.1475-6773.2012.01440.x · Cited by 114 · see citing works
Norepinephrine transporter function and human cardiovascular disease
Schroeder, C., & Jordan, J. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00492.2012 · Cited by 109 · see citing works
Ramos-Quiroga, J., Montoya, A., Kutzelnigg, A., Deberdt, W., & Sobanski, E. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.812961 · Cited by 113 · see citing works
Zhang, L., Yao, H., Li, L., Rietz, E. D., Andell, P., Garcia‐Argibay, M., D'Onofrio, B. M., Cortese, S., Larsson, H., & Chang, Z. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.43597 · Cited by 107 · see citing works
Brikell, I., Yao, H., Li, L., Astrup, A., Gao, L., Gillies, M. B., Xie, T., Zhang‐James, Y., Dalsgaard, S., Engeland, A., et al. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00332-2 · Cited by 93 · see citing works
Zalsman, G., & Shilton, T. (2016) · International journal of psychiatry in clinical practice · doi:10.3109/13651501.2016.1149197 · Cited by 90 · see citing works
A Systematic Review of the Safety of Lisdexamfetamine Dimesylate
Coghill, D. R., Caballero, B., Sorooshian, S., & Civil, R. (2014) · CNS Drugs · doi:10.1007/s40263-014-0166-2 · Cited by 89 · see citing works
Stimulant Drugs of Abuse and Cardiac Arrhythmias
Dominic, P. S., Ahmad, J., Awwab, H., Bhuiyan, M. S., Kevil, C. G., Goeders, N. E., Murnane, K. S., Patterson, J. C., Sandau, K. E., Gopinathannair, R., et al. (2021) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.121.010273 · Cited by 88 · see citing works
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Storm, M. R. O., Ribeiro, J. P., Skoog, M., Groth, C., Edemann-Callesen, H., Schaug, J. P., Rasmussen, P. D., Huus, C.-M. L., Zwi, M., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub3 · Cited by 86 · see citing works
Complications and Continuation of Intrauterine Device Use Among Commercially Insured Teenagers
Berenson, A. B., Tan, A., Hirth, J. M., & Wilkinson, G. S. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31828b63a0 · Cited by 85 · see citing works
Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
Jaeschke, R. R., Sujkowska, E., & Sowa-Kućma, M. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05946-0 · Cited by 90 · see citing works
Heart rate variability and methylphenidate in children with ADHD
Buchhorn, R., Conzelmann, A., Willaschek, C., Störk, D., Taurines, R., & Renner, T. J. (2012) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-012-0072-8 · Cited by 79 · see citing works
Association of ADHD medications with the risk of cardiovascular diseases: a meta-analysis
Liu, H., Feng, W., & Zhang, D. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1217-x · Cited by 72 · see citing works
Cardiovascular Effects of ADHD Therapies
Torres-Acosta, N., O’Keefe, J. H., O’Keefe, C. L., & Lavie, C. J. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.081 · Cited by 65 · see citing works
Karlstad, Ø., Zoega, H., Furu, K., Bahmanyar, S., Martikainen, J., Kieler, H., & Pottegård, A. (2016) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-016-2125-y · Cited by 51 · see citing works
Effect of psychostimulants on blood pressure profile and endothelial function in narcolepsy
Bosco, A., Lopez, R., Barateau, L., Chenini, S., Pesenti, C., Pépin, J., Jaussent, I., & Dauvilliers, Y. A. (2018) · Neurology · doi:10.1212/wnl.0000000000004911 · Cited by 65 · see citing works
Johansson, B. E. A., Wentzel, A.-P., Andréll, P., Odenstedt, J., Mannheimer, C., & Rönnbäck, L. (2013) · Brain Injury · doi:10.3109/02699052.2013.865267 · Cited by 64 · see citing works
Developments and challenges in the diagnosis and treatment of ADHD
Dias, T. G. C., Kieling, C., Graeff-Martins, A. S., Moriyama, T. S., Rohde, L. A., & Polanczyk, G. V. (2013) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2013-s103 · Cited by 62 · see citing works
Li, L., Yao, H., Zhang, L., Garcia‐Argibay, M., Du Rietz, E., Brikell, I., Solmi, M., Cortese, S., Ramos‐Quiroga, J. A., Ribasés, M., et al. (2023) · JCPP Advances · doi:10.1002/jcv2.12158 · Cited by 55 · see citing works
Bain, E., Robieson, W., Pritchett, Y., Garimella, T. S., Abi‐Saab, W., Apostol, G., McGough, J. J., & Saltarelli, M. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.194 · Cited by 55 · see citing works
From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate
Busardò, F., Kyriakou, C., Cipolloni, L., Zaami, S., & Frati, P. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150407225902 · Cited by 52 · see citing works
Ozgen, H., Spijkerman, R., Noack, M., Holtmann, M., Schellekens, A., van de Glind, G., Banaschewski, T., Barta, C., Begeman, A., Casas, M., et al. (2020) · European Addiction Research · doi:10.1159/000508385 · Cited by 45 · see citing works
Chen, X., Faviez, C., Schück, S., Louët, A. L., Texier, N., Badisse Dahamna, A., Huot, C., Foulquié, P., Pereira, S., Leroux, V., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00541 · Cited by 52 · see citing works
Attention-deficit/hyperactivity disorder (ADHD)
Dalsgaard, S. (2012) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0360-z · Cited by 51 · see citing works
Assessment of stimulant use and cardiovascular event risks among older adults
Tadrous, M., Shakeri, A., Chu, C., Watt, J., Mamdani, M. M., Juurlink, D. N., & Gomes, T. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.30795 · Cited by 49 · see citing works
Groenman, A. P., Schweren, L. J. S., Dietrich, A., & Hoekstra, P. J. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1301928 · Cited by 46 · see citing works
Clemow, D. B. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_426 · Cited by 48 · see citing works
Pharmacotherapy of Aggression in Child and Adolescent Psychiatric Disorders
Gurnani, T., Ivanov, I., & Newcorn, J. H. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0167 · Cited by 48 · see citing works
Pediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD
Clavenna, A., & Bonati, M. R. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1389894 · Cited by 47 · see citing works
Cardiovascular toxicity of novel psychoactive drugs: Lessons from the past
Dawson, P., & Moffatt, J. D. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.05.003 · Cited by 46 · see citing works
Attention Deficit Hyperactivity Disorder and Athletes
White, R. D., Harris, G. D., & Gibson, M. E. (2013) · Sports Health A Multidisciplinary Approach · doi:10.1177/1941738113484679 · Cited by 45 · see citing works
López, F. A., & Leroux, J. R. (2013) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-013-0106-x · Cited by 43 · see citing works
Martínez-Raga, J., Ferreros, A., Knecht, C., de Alvaro, R., & Carabal, E. (2017) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098616679636 · Cited by 31 · see citing works
Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale
Manolis, T. A., Manolis, A. S., & Manolis, A. S. (2018) · Angiology · doi:10.1177/0003319718780145 · Cited by 39 · see citing works
Langner, I., Garbe, E., Banaschewski, T., & Mikolajczyk, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062177 · Cited by 32 · see citing works
The ethics of neuroenhancement
Chatterjee, A. K. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53501-6.00027-5 · Cited by 36 · see citing works
Mukherjee, J., Baranwal, A., & Schade, K. N. (2016) · Current Diabetes Reviews · doi:10.2174/1573399812666160517115450 · Cited by 35 · see citing works
Kelly, A. S., Rudser, K. D., Dengel, D. R., Kaufman, C. L., REIFF, M. I., Norris, A. L., Metzig, A. M., & Steinberger, J. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.05.043 · Cited by 36 · see citing works
Brumbaugh, S., Tuan, W., Scott, A. R., Latronica, J. R., & Bone, C. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101524 · Cited by 35 · see citing works
Methylphenidate off-label use and safety
Trenque, T. C., Herlem, E., Taam, M. A., & Dramé, M. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-286 · Cited by 35 · see citing works
Long‐QT Syndrome and Therapy for Attention Deficit/Hyperactivity Disorder
Zhang, C., Kutyifa, V., Moss, A. J., McNitt, S. A., Zaręba, W., & Kaufman, E. S. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12739 · Cited by 34 · see citing works
Kollins, S. H., Schoenfelder, E. N., English, J. S., Holdaway, A. S., Voorhees, E. E. V., O’Brien, B., Dew, R. E., & Chrisman, A. K. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.07.014 · Cited by 34 · see citing works
Leschziner, G. D. (2014) · Practical Neurology · doi:10.1136/practneurol-2014-000837 · Cited by 34 · see citing works
Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement?
Kapur, A. (2020) · CNS Drugs · doi:10.1007/s40263-020-00758-w · Cited by 34 · see citing works
The Heartwarming Effect of Brown Adipose Tissue
Pinckard, K. M., & Stanford, K. I. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000328 · Cited by 33 · see citing works
Lensing, M. B., Zeiner, P., Sandvik, L., & Opjordsmoen, S. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07714 · Cited by 32 · see citing works
Quantin, C., Benzenine, É., Velten, M., Huet, F., Farrington, P., & Tubert‐Bitter, P. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt207 · Cited by 32 · see citing works
Diagnosis and management of adult attention-deficit/hyperactivity disorder.
Post, R. E., & Kurlansik, S. L. (2012) · PubMed · Cited by 32 · see citing works
Abelman, D. D. (2017) · Harm Reduction Journal · doi:10.1186/s12954-017-0194-6 · Cited by 32 · see citing works
Fredriksen, M., & Peleikis, D. E. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12477 · Cited by 31 · see citing works
Methylphenidate and short-term cardiovascular risk
Garcia-Argibay, M., Bürkner, P.-C., Lichtenstein, P., Zhang, L., D’Onofrio, B. M., Andell, P., Chang, Z., Cortese, S., & Larsson, H. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.1349 · Cited by 31 · see citing works
Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?
Hammerness, P. G., Karampahtsis, C., Babalola, R., & Alexander, M. E. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1011620 · Cited by 32 · see citing works
Managing the Risks of ADHD Treatments
Schneider, B. N., & Enenbach, M. J. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0479-3 · Cited by 29 · see citing works
Camporeale, A., Porsdal, V., Bruyckere, K. D., Tanaka, Y., Upadhyaya, H., Deix, C., & Deberdt, W. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114560183 · Cited by 29 · see citing works
Leijenaar, J. F., Groeneveld, G. J., Klaassen, E. S., Leeuwis, A. E., Scheltens, P., Weinstein, H. C., van Gerven, J., Barkhof, F., van der Flier, W. M., & Prins, N. D. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0567-z · Cited by 26 · see citing works
Besag, F. (2014) · Drug Safety · doi:10.1007/s40264-014-0168-5 · Cited by 26 · see citing works
McCarthy, S., Neubert, A., Man, K. K. C., Banaschewski, T., Buitelaar, J., Carucci, S., Coghill, D., Danckaerts, M., Falissard, B., Garas, P., et al. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1884-7 · Cited by 25 · see citing works
Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in Adults
Schelleman, H., Bilker, W. B., Kimmel, S. E., Daniel, G. W., Newcomb, C. W., Guevara, J. P., Cziraky, M. J., Strom, B. L., & Hennessy, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052991 · Cited by 25 · see citing works
A Review of Psychostimulants for Adults With Depression.
Pary, R., Scarff, J. R., Jijakli, A., TOBIAS, C. R., & Lippmann, S. (2015) · Europe PMC (PubMed Central) · Cited by 24 · see citing works
Houghton, R., de Vries, F., & Loss, G. J. (2019) · CNS Drugs · doi:10.1007/s40263-019-00686-4 · Cited by 25 · see citing works
Mirbolooki, M., Constantinescu, C. C., Pan, M., & Mukherjee, J. (2012) · Synapse · doi:10.1002/syn.21617 · Cited by 24 · see citing works
The intraindividual impact of ADHD on the transition of adulthood to old age
Philipp-Wiegmann, F., Retz-Junginger, P., Retz, W., & Rösler, M. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-015-0644-7 · Cited by 27 · see citing works
Buchhorn, R., Müller, C., Willaschek, C., & Norozi, K. (2012) · ISRN Pharmacology · doi:10.5402/2012/170935 · Cited by 22 · see citing works
Neurofeedback game for attention training in adults
Ochi, Y., Laksanasopin, T., Kaewkamnerdpong, B., & Thanasuan, K. (2017) · Biomedical Engineering International Conference · doi:10.1109/bmeicon.2017.8229113 · Cited by 22 · see citing works
Temporal trends in sudden cardiac death in Ontario, Canada
Shuvy, M., Qiu, F., Lau, G., Koh, M., Dorian, P., Géri, G., Lin, S., & Ko, D. T. (2019) · Resuscitation · doi:10.1016/j.resuscitation.2019.01.010 · Cited by 22 · see citing works
Cardiovascular Effects of Drugs Used to Treat Attention-Deficit/Hyperactivity Disorder Part 2
Fay, T. B., & Alpert, M. (2018) · Cardiology in Review · doi:10.1097/crd.0000000000000234 · Cited by 22 · see citing works
Lamberti, M., Italiano, D., Guerriero, L., D’Amico, G., Siracusano, R., Ingrassia, M., Germanò, E., Calabrò, M. P., Spina, E., & Gagliano, A. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s79866 · Cited by 21 · see citing works
Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder
Walker, D., Mason, O. W., Clemow, D., & Day, K. (2015) · Postgraduate medicine · doi:10.1080/00325481.2015.1081046 · Cited by 25 · see citing works
Bazelier, M. T., Eriksson, I., de Vries, F., Schmidt, M. K., Raitanen, J. A., Haukka, J. K., Starup‐Linde, J., Bruin, M. L. D., & Andersen, M. T. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3828 · Cited by 20 · see citing works
Adult ADHD Medications and Their Cardiovascular Implications
Sinha, A., Lewis, O., Kumar, R., Yeruva, S. L. H., & Curry, B. H. (2016) · Case Reports in Cardiology · doi:10.1155/2016/2343691 · Cited by 20 · see citing works
The Prescription Drug Abuse Epidemic
Yu, H.-Y. E. (2012) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2012.06.006 · Cited by 19 · see citing works
The safety of extended-release drug formulations for the treatment of ADHD
Childress, A. C. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1317344 · Cited by 19 · see citing works
Mazza, M., D'Ascenzo, F., Davico, C., Biondi-Zoccai, G., Frati, G., Romagnoli, E., Bassi, B., Janiri, L., Moretti, C., & Gaita, F. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.04.169 · Cited by 18 · see citing works
Pharmacological treatment of adult ADHD
Bitter, I., Angyalosi, A., & Czobor, P. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328356f87f · Cited by 18 · see citing works
Parisi, P., Villa, M. P., Donfrancesco, R., Miano, S., Paolino, M. C., & Cortese, S. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.04.049 · Cited by 18 · see citing works
- Authors
- Habel, L. A., Cooper, W. O., Sox, C. M., Chan, K. A., Fireman, B. H., Arbogast, P. G., Cheetham, T. C., Quinn, V. P., Dublin, S., Boudreau, D. M., Andrade, S. E., Pawloski, P. A., Raebel, M. A., Smith, D. H., Achacoso, N., Uratsu, C., Go, A. S., Sidney, S., Nguyen-Huynh, M. N., Ray, W. A., & Selby, J. V.
- Affiliations
- Kaiser Permanente (US)
- Boston University (US)
- Regions Hospital (US)
- University of California, San Francisco (US)
- Corresponding author
- Habel, Laurel A.
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2011-12-28
- Volume
- 306
- Issue
- 24
- Pages
- 2673
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC3350308
- OpenAlex
- W2122411644
- Cited by
- 297
- References
- 40
- Citations by year
- 2026: 13 · 2025: 9 · 2024: 14 · 2023: 17 · 2022: 16 · 2021: 18 · 2020: 19 · 2019: 16 · 2018: 15 · 2017: 17 · 2016: 15 · 2015: 23 · 2014: 24 · 2013: 29 · 2012: 49
- FWCI
- 22.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- U.S. Public Health Service (223-2005-10100C, 223-2005-10012C, HHSA290-2005-0033, 223-2005-20006C, HHSA290-2005-0042, 223-2005-10012)
- National Institute on Aging (K23AG028954)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- attention deficit hyperactivity disorder, ADHD medication, cardiovascular events, myocardial infarction, sudden cardiac death, stroke, methylphenidate, amphetamine, atomoxetine, stimulants, cardiovascular safety, young and middle-aged adults, healthy user bias, heart rate, blood pressure, medication dispensing, Medicaid, Kaiser Permanente
- MeSH terms
- Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Cardiovascular Diseases, Female, Humans, Male, Middle Aged, Myocardial Infarction, Retrospective Studies, Risk, Cohort Studies, Death, Sudden, Cardiac, Stroke, Electronic Health Records
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
